You have 9 free searches left this month | for more free features.

Nucleoside Analog

Showing 1 - 25 of 1,775

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PET Imaging of the Immune System Using Analog Probes

Completed
  • Malignant Melanoma
  • [18F] CFA
  • Los Angeles, California
    University of California, Los Angeles
Oct 8, 2021

HIV Trial in Aurora (zidovudine 300mg and lamivudine 150mg as Combivir)

Completed
  • HIV
  • zidovudine 300mg and lamivudine 150mg as Combivir
  • Aurora, Colorado
    University of Colorado Denver and Health Sciences Center
Mar 2, 2020

HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Efavirenz)

Completed
  • HIV Infections
  • Indinavir sulfate
  • +2 more
  • Los Angeles, California
  • +55 more
Oct 28, 2021

HIV Trial in Spain (Nevirapine, Efavirenz, Indinavir/ritonavir)

Completed
  • HIV Infections
  • Badalona, Barcelona, Spain
  • +5 more
Dec 3, 2019

Treatment Optimization of Refractory

Recruiting
  • Hepatitis B, Chronic
  • Virus Diseases
  • original therapy
  • rescue therapy
  • Ankang, China
  • +12 more
Feb 1, 2023

HIV Trial in Puerto Rico, United States (Nevirapine, Zidovudine, Zalcitabine)

Completed
  • HIV Infections
  • Birmingham, Alabama
  • +95 more
Oct 27, 2021

Antiviral Therapy for Patients With Liver Cancer After Surgery

Recruiting
  • Hepatocellular Carcinoma
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Jul 19, 2022

    HIV Trial in United States (Amprenavir, Lamivudine, Zidovudine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +14 more
    Oct 28, 2021

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Tumors, Solid Tumors Trial run by the NCI (TdCyd)

    Suspended
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2022

    Glioblastoma Trial (RZ-001, VGCV)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Oct 22, 2023

    HIV Trial in Puerto Rico, United States (Stavudine, Zidovudine, Didanosine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +32 more
    Oct 28, 2021

    HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

    Recruiting
    • HIV/AIDS
    • Tuberculosis, Pulmonary
    • Biktarvy®
    • TLD- fixed-drug combination single tablet
    • Durban, KwaZulu-Natal, South Africa
      CAPRISA Springfield Clinical Research Site
    Mar 14, 2022

    Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

    Completed
    • Neoplasms
    • FdCyd + THU
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Chronic Hepatitis B Trial in Changchun (GLS4, RTV, TAF)

    Completed
    • Chronic Hepatitis B
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    May 20, 2022

    Chronic Hepatitis B Trial in Guangzhou (Peginterferon Alfa, Nucleoside Analog (Substance))

    Unknown status
    • Chronic Hepatitis B
    • Peginterferon Alfa
    • Nucleoside Analog (Substance)
    • Guangzhou, Guangdong, China
      Department of Infectious Diseases, The Third Affliated Hospital
    Jan 12, 2019

    Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Durvalumab
    • +5 more
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +2 more
    • CD19-CAR(Mem) T-cells
    • +5 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 5, 2022

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

    Terminated
    • Advanced Solid Tumor
    • +3 more
    • Darlinghurst, New South Wales, Australia
    • +1 more
    Dec 18, 2022

    Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

    Recruiting
    • Chronic Hepatitis b Patients
    • Tenofovir Disoproxil Fumarate and Entcavir
    • Sohag, Egypt
      Sohag University hospitals
    May 22, 2023

    HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Efavirenz)

    Completed
    • HIV Infections
    • Chicago, Illinois
    • +5 more
    Oct 28, 2021

    AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

    Recruiting
    • AML
    • +4 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
    • +1 more
    May 10, 2022

    HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Nevirapine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +54 more
    Oct 28, 2021

    Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

    Completed
    • Medication Adherence
    • HIV
    • dolutegravir oral tablet 50mg
    • +3 more
    • Pittsburgh, Pennsylvania
      HIV/AIDS Clinical Research Unit / University of Pittsburgh
    Mar 2, 2022